U.S. Markets open in 3 hrs 15 mins

AxoGen, Inc. (AXGN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
18.55-0.10 (-0.54%)
At close: 4:00PM EDT
People also watch
BLFSATRCCASMBIOLASMB

AxoGen, Inc.

13631 Progress Boulevard
Suite 400
Alachua, FL 32615
United States
386-462-6800
http://www.axogeninc.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees138

Key Executives

NameTitlePayExercisedAge
Ms. Karen ZaderejChief Exec. Officer, Pres and Director661.07kN/A55
Mr. Peter J. MarianiChief Financial Officer390.05kN/A53
Mr. Gregory G. Freitag Esq., J.D., CPASr. VP of Bus. Devel., Gen. Counsel and Director306.25kN/A55
Mr. Michael DonavanVP of OperationsN/AN/A52
Mr. Shawn F. McCarreySr. VP of SalesN/AN/A59
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company’s surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

Corporate Governance

AxoGen, Inc.’s ISS Governance QualityScore as of September 1, 2017 is 2. The pillar scores are Audit: 10; Board: 4; Shareholder Rights: 1; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.